We identified 26 transcripts that are perturbed by NFκB andhad a regulatory variant linked to a complex disease, including immune-related and/or autoimmunediseases such as systemic lupus erythematosus (SLE), multiple sclerosis and Kawasaki disease(Supplementary Table S9). This evidence concerns the gene NFKB1 and systemic lupus erythematosus.